by Ethan Perlstein | Jun 14, 2018 | Rare Diseases |
I just attended the 2018 Michael, Marcia, and Christa Parseghian Scientific Conference for Niemann-Pick Type C (NPC) research. My mind is still spinning from all the productive interactions and conversations I had over three session-packed days at The Westin La Paloma...
by Aras Rezvanian | May 23, 2018 | Science |
One of the rare genetic disorders that we at Perlara have been working on is Mucolipidosis type IV (MLIV) – one of the Mucolipidosis group of inherited lysosomal storage disorders. For background on MLIV, and to learn more about our work in optimizing a MLIV drug...
by Zach Parton | May 17, 2018 | Science |
In 2016, Perlara and Wylder Nation launched a PerlQuest to find a cure for Niemann-Pick Type A (NPA). We have also been developing simple organism disease models for Niemann-Pick Type C (NPC) as a part of our research collaboration with Novartis. An interesting...
by Ethan Perlstein | Apr 6, 2018 | MSD |
I’m excited to share the latest news! Today we announced our sixth PerlQuest partnership. Our PerlQuest partner is the Multiple Sulfatase Deficiency Action Foundation (MSDAF), a research-focused charity based in Ireland whose mission is to work towards a cure for...
by Joshua Mast | Jan 22, 2018 | Niemann-Pick Type A |
A few months ago, Taryn Sumabat blogged about development of a fly model of a Niemann-Pick Type A Disease. Here I’ll remind you of the progress she described, and update you on our more recent work. If you remember, the two main objectives for this phase of our NPA...
